Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

Does ALISKIREN\HYDROCHLOROTHIAZIDE Cause Fatigue? 5 Reports in FDA Database

Lower Your Cholesterol — The Natural Way

The Oxidized Cholesterol Strategy: a science-backed plan for heart health.

See the Strategy

According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Fatigue have been filed in association with ALISKIREN\HYDROCHLOROTHIAZIDE. This represents 4.2% of all adverse event reports for ALISKIREN\HYDROCHLOROTHIAZIDE.

5
Reports of Fatigue with ALISKIREN\HYDROCHLOROTHIAZIDE
4.2%
of all ALISKIREN\HYDROCHLOROTHIAZIDE reports
0
Deaths
2
Hospitalizations

How Dangerous Is Fatigue From ALISKIREN\HYDROCHLOROTHIAZIDE?

Of the 5 reports, 2 (40.0%) required hospitalization, and 2 (40.0%) were considered life-threatening.

Is Fatigue Listed in the Official Label?

This adverse event is not currently listed in the official FDA drug label for ALISKIREN\HYDROCHLOROTHIAZIDE. However, 5 reports have been filed with the FAERS database.

What Other Side Effects Does ALISKIREN\HYDROCHLOROTHIAZIDE Cause?

Dizziness (21) Blood pressure increased (19) Dementia (17) Haematochezia (17) Malaise (10) Weight decreased (9) Hypertension (8) Hyponatraemia (8) Asthma (7) Blood immunoglobulin e increased (7)

What Other Drugs Cause Fatigue?

ADALIMUMAB (29,420) LENALIDOMIDE (22,956) ETANERCEPT (19,907) METHOTREXATE (19,885) RITUXIMAB (15,602) PALBOCICLIB (15,190) PREDNISONE (14,320) TOCILIZUMAB (13,802) TOFACITINIB (13,551) INFLIXIMAB (13,473)

Which ALISKIREN\HYDROCHLOROTHIAZIDE Alternatives Have Lower Fatigue Risk?

ALISKIREN\HYDROCHLOROTHIAZIDE vs ALIZAPRIDE ALISKIREN\HYDROCHLOROTHIAZIDE vs ALLANTOIN ALISKIREN\HYDROCHLOROTHIAZIDE vs ALLEGRA ALISKIREN\HYDROCHLOROTHIAZIDE vs ALLEGRA 24 HOUR ALISKIREN\HYDROCHLOROTHIAZIDE vs ALLEGRA D

Related Pages

ALISKIREN\HYDROCHLOROTHIAZIDE Full Profile All Fatigue Reports All Drugs Causing Fatigue ALISKIREN\HYDROCHLOROTHIAZIDE Demographics